KBC Group NV Sells 1,655 Shares of Sotera Health (NASDAQ:SHC)

KBC Group NV lowered its stake in shares of Sotera Health (NASDAQ:SHC) by 27.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,443 shares of the company’s stock after selling 1,655 shares during the period. KBC Group NV’s holdings in Sotera Health were worth $74,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Janus Henderson Group PLC lifted its stake in Sotera Health by 43.6% in the 1st quarter. Janus Henderson Group PLC now owns 14,892,868 shares of the company’s stock valued at $178,865,000 after purchasing an additional 4,525,056 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Sotera Health by 27.0% in the first quarter. Vanguard Group Inc. now owns 12,145,110 shares of the company’s stock valued at $145,863,000 after buying an additional 2,579,248 shares during the last quarter. Darsana Capital Partners LP acquired a new stake in shares of Sotera Health in the second quarter valued at approximately $29,074,000. Khrom Capital Management LLC bought a new position in shares of Sotera Health during the 1st quarter worth approximately $14,626,000. Finally, AQR Capital Management LLC increased its holdings in shares of Sotera Health by 3,198.2% during the 2nd quarter. AQR Capital Management LLC now owns 511,580 shares of the company’s stock worth $6,072,000 after acquiring an additional 496,069 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Trading Up 3.3 %

Shares of Sotera Health stock opened at $12.82 on Friday. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The firm has a 50-day moving average of $15.61 and a 200-day moving average of $13.94. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.44. The stock has a market cap of $3.63 billion, a PE ratio of 51.28 and a beta of 2.08.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business had revenue of $285.47 million during the quarter, compared to the consensus estimate of $278.64 million. During the same period in the prior year, the firm earned $0.18 EPS. The business’s revenue for the quarter was up 8.5% on a year-over-year basis. As a group, sell-side analysts forecast that Sotera Health will post 0.61 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on SHC shares. Citigroup raised their price target on Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Barclays raised their target price on shares of Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 6th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a research note on Thursday. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Sotera Health has an average rating of “Moderate Buy” and a consensus price target of $16.50.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the transaction, the director now directly owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. This trade represents a 16.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 55.12% of the stock is currently owned by company insiders.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.